IUPHAR review: Eating disorders, gut microbiota dysbiosis and epigenetic aberrations

IF 9.1 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Shabnam Nohesara , Hamid Mostafavi Abdolmaleky , Giuseppe Pettinato , Ahmad Pirani , Sam Thiagalingam , Jin-Rong Zhou
{"title":"IUPHAR review: Eating disorders, gut microbiota dysbiosis and epigenetic aberrations","authors":"Shabnam Nohesara ,&nbsp;Hamid Mostafavi Abdolmaleky ,&nbsp;Giuseppe Pettinato ,&nbsp;Ahmad Pirani ,&nbsp;Sam Thiagalingam ,&nbsp;Jin-Rong Zhou","doi":"10.1016/j.phrs.2025.107653","DOIUrl":null,"url":null,"abstract":"<div><div>Eating disorders (EDs) are a heterogeneous class of increasing mental disorders that are characterized by disturbances in eating behaviors, body weight regulation, and associated psychological dysfunctions. These disorders create physiological imbalances that alter the diversity and composition of the gut microbiota. While evidence suggests that EDs can arise from epigenetic aberrations, alterations in gut microbial communities may also contribute to the development and/or persistence of EDs through epigenetic mechanisms. Understanding the interplay among gut microbial communities, epigenetic processes, and the risk of EDs provides opportunities for designing preventive and/or therapeutic interventions through gut microbiome modulation. This review highlights how microbiome-based therapeutics and specific dietary interventions can contribute to improving various subtypes of EDs by modulating gut microbial communities and mitigating epigenetic aberrations. First, we briefly review the literature on links between epigenetic aberrations and the pathophysiology of EDs. Second, we examine the potential role of the gut microbiome in the pathogenesis of EDs through epigenetic mechanisms. Next, we explore the associations between EDs and other psychiatric disorders, and examine the potential roles of the microbiome in their pathogenesis. Finally, we present evidence supporting the potential of microbiome-based therapeutics and specific dietary interventions to improve EDs through epigenetic modifications.</div></div>","PeriodicalId":19918,"journal":{"name":"Pharmacological research","volume":"213 ","pages":"Article 107653"},"PeriodicalIF":9.1000,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1043661825000787","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Eating disorders (EDs) are a heterogeneous class of increasing mental disorders that are characterized by disturbances in eating behaviors, body weight regulation, and associated psychological dysfunctions. These disorders create physiological imbalances that alter the diversity and composition of the gut microbiota. While evidence suggests that EDs can arise from epigenetic aberrations, alterations in gut microbial communities may also contribute to the development and/or persistence of EDs through epigenetic mechanisms. Understanding the interplay among gut microbial communities, epigenetic processes, and the risk of EDs provides opportunities for designing preventive and/or therapeutic interventions through gut microbiome modulation. This review highlights how microbiome-based therapeutics and specific dietary interventions can contribute to improving various subtypes of EDs by modulating gut microbial communities and mitigating epigenetic aberrations. First, we briefly review the literature on links between epigenetic aberrations and the pathophysiology of EDs. Second, we examine the potential role of the gut microbiome in the pathogenesis of EDs through epigenetic mechanisms. Next, we explore the associations between EDs and other psychiatric disorders, and examine the potential roles of the microbiome in their pathogenesis. Finally, we present evidence supporting the potential of microbiome-based therapeutics and specific dietary interventions to improve EDs through epigenetic modifications.
IUPHAR综述:饮食失调,肠道微生物群失调和表观遗传畸变。
饮食失调(EDs)是一类异质性的精神障碍,其特征是饮食行为、体重调节和相关的心理功能障碍。这些疾病造成生理失衡,改变了肠道微生物群的多样性和组成。虽然有证据表明ed可能由表观遗传畸变引起,但肠道微生物群落的改变也可能通过表观遗传机制促进ed的发展和/或持续存在。了解肠道微生物群落、表观遗传过程和ed风险之间的相互作用,为通过肠道微生物组调节设计预防和/或治疗干预提供了机会。这篇综述强调了基于微生物组的治疗方法和特定的饮食干预如何通过调节肠道微生物群落和减轻表观遗传畸变来改善各种ed亚型。首先,我们简要回顾了表观遗传畸变与ed病理生理之间联系的文献。其次,我们通过表观遗传机制研究肠道微生物组在EDs发病机制中的潜在作用。接下来,我们将探讨ed与其他精神疾病之间的联系,并研究微生物组在其发病机制中的潜在作用。最后,我们提出证据支持基于微生物组的治疗方法和特定饮食干预通过表观遗传修饰改善ed的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmacological research
Pharmacological research 医学-药学
CiteScore
18.70
自引率
3.20%
发文量
491
审稿时长
8 days
期刊介绍: Pharmacological Research publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. Pharmacological research publishes articles on molecular, biochemical, translational, and clinical research (including clinical trials); it is proud of its rapid publication of accepted papers that comprises a dedicated, fast acceptance and publication track for high profile articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信